Intended for healthcare professionals

Editorials

Selling NHS patient data

BMJ 2024; 384 doi: https://doi.org/10.1136/bmj.q420 (Published 22 February 2024) Cite this as: BMJ 2024;384:q420
  1. Jessica Morley, postdoctoral associate1,
  2. Nicola Hamilton, head2,
  3. Luciano Floridi, professor1 3
  1. 1Digital Ethics Center, Yale University, New Haven, CT, USA
  2. 2Understanding Patient Data, London, UK
  3. 3Department of Legal Studies, University of Bologna, Bologna, Italy
  4. Correspondence to: J Morley jessica.morley@yale.edu

The next government must resist a retail model of data management

The NHS is in crisis.1 Resolving it is a major focus of the forthcoming general election, and several high profile publications have recently set out recommendations for the next government. The recommendation from former party leaders Tony Blair and William Hague that NHS data should be harnessed for commercial purposes has garnered considerable attention. They propose establishing an NHS data trust as a public-private company to facilitate use of NHS data for both public health research and commercially successful artificial intelligence (AI) innovation.2 This has been widely, and correctly, interpreted as a recommendation to sell NHS data to fuel a cost cutting and efficiency boosting AI revolution.34

The recommendation itself avoids using the word “sell.” Yet the discussion in the full report, published by the Tony Blair Institute for Global Change, makes the “selling” interpretation unavoidable. The BBC is used as an exemplar of a public organisation …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription